sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY July 2015 | Archived Issues

P & T Approvals, FDA Warnings About Codeine-Containing Meds, NSAIDS, Proglycem

Pharmacy Focus

See highlights of the June meeting of the Pharmacy and Therapeutics Committee. Also, the U.S. Food and Drug Administration has issued warnings about codeine-containing medicines in children, nonsteroidal anti-inflammatory drugs and Proglycem in infants.


Mark Your Calendar


Grand Rounds

Click here to view a schedule of all upcoming grand rounds.


Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Establishment of a New Orthopedic Academic Department

Message From the Chair

The Division of Orthopaedic Surgery has long been recognized for its high-quality care and treatment of musculoskeletal disorders and diseases. The strength of the program arises from a multidisciplinary team of experts that includes more than 80 orthopedic surgeons on the voluntary and full-time faculty, many of whom hold national positions of leadership.

In 2014, Cedars-Sinai was rated seventh nationally in the U.S. News & World Report list of top hospitals in orthopedics; it had the top orthopedic program on the West Coast. Importantly, Cedars-Sinai has the only orthopedics program in the top 10 that is not structured as an independent department. The Department of Surgery believes the program has the potential to achieve even a stronger academic reputation among specialists in the field with the addition of departmental status.

Our recent proposal to form such a department was advanced through the Surgery Department and approved by the Medical Executive Committee; board approval is expected July 27, 2015.

Given demographic trends, orthopedics is poised to be a top volume contributor over the next 10 years, with a projected inpatient growth rate of 15 percent and outpatient growth rate of 28 percent. While the Medicare population will continue to grow in orthopedics and the reimbursement for this segment will be heavily controlled by the government, the market trend to more outpatient procedures and the Orthopaedic Division's favorable outpatient payer mix set the foundation for strong financials in the coming years.

The academic component at Cedars-Sinai is still growing compared to the other Top 10 programs. The orthopedic residency was established in 2011 and currently has 20 Accreditation Council for Graduate Medical Education (ACGME) positions. In 2015, there were 555 applicants for the four yearly spots at Cedars-Sinai, representing a 42 percent increase in applications over four years. The quality of the applicants is outstanding, with more than 100 American Osteopathic Association graduates applying each year. The division has established 16 fellowships, 13 of which are ACGME positions. The Division of Orthopaedics currently has $2.4 million awarded for basic and translational research. This very respectable amount includes funds from the National Institutes of Health, the California Institute for Regenerative Medicine and other sources.

The prominence of Cedars-Sinai Orthopaedics has led to a number of other unique opportunities:

  • We have been contracted to provide orthopedic care to Boeing employees in the western United States. This was a highly competitive process and highlights our reputation for quality.
  • A recent affiliation with Kerlan-Jobe Orthopaedic Clinic and Santa Monica Orthopaedic and Sports Medicine Group through the Medical Network was another solid step in strengthening our reputation. Kerlan-Jobe and SMOG bring expertise and status in the professional sports world.
  • Cedars-Sinai, UCLA Health System and Select Medical Holdings will open a 138-bed rehabilitation hospital in Century City, reflecting the growing need for this specialty care and a key resource for the growing orthopedic market.

Creating an Orthopaedic Department at Cedars-Sinai will continue our reputational momentum and better position us to recruit the top clinical and research talent from across the country. Further, we can develop the academic components consistent with the strongest orthopedic group west of the Mississippi.

Please join me in congratulating the leadership of Orthopaedics, including Will Brien, MD, section chief, Robert Bernstein, MD, medical director of the Orthopaedic Center, and their colleagues, on this well-deserved change in structure.

Bruce L. Gewertz, MD
Surgeon-in-Chief
H and S Nichols Distinguished Chair in Surgery
Chair, Department of Surgery
Vice President, Interventional Services
Vice Dean, Academic Affairs